Krittika Tanyasaensook
(Chulalongkorn University, 2007)
To demonstrate the synergism between 90Yttrium ibritumomab tiuxetan (Y2B8) and commonly used antilymphoma drugs. The study was separated into 2 parts. First, to demonstrate the in vitro synergy in terms of direct cytotoxicity ...